共 61 条
- [1] Cottereau AS(2018)Is there an optimal method for measuring baseline metabolic tumor volume in diffuse large B cell lymphoma? Eur J Nucl Med Mol Imaging 45 1463-1464
- [2] Buvat I(2018)Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma Eur J Nucl Med Mol Imaging 45 1142-1154
- [3] Kanoun S(2017)Obinutuzumab or rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone in previously untreated diffuse large b-cell lymphoma J Clin Oncol 35 3529-3537
- [4] Versari A(2015)Influence of software tool and methodological aspects of total metabolic tumor volume calculation on baseline [18F]FDG PET to predict survival in Hodgkin lymphoma PLoS One 10 e0140830-2022
- [5] Casasnovas O(2014)Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma Eur J Nucl Med Mol Imaging 41 2017-undefined
- [6] Chauvie S(undefined)undefined undefined undefined undefined-undefined
- [7] Clerc J(undefined)undefined undefined undefined undefined-undefined
- [8] Gallamini A(undefined)undefined undefined undefined undefined-undefined
- [9] Meignan M(undefined)undefined undefined undefined undefined-undefined
- [10] Ilyas H(undefined)undefined undefined undefined undefined-undefined